Compare · MDLN vs VERO
MDLN vs VERO
Side-by-side comparison of Medline Inc. (MDLN) and Venus Concept Inc. (VERO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and VERO operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $46.86B, about 534.5x VERO ($87.7M).
- MDLN has hit the wire 12 times in the past 4 weeks while VERO has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for VERO).
- Company
- Medline Inc.
- Venus Concept Inc.
- Price
- $35.64+2.77%
- $1.14-6.20%
- Market cap
- $46.86B
- $87.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2017
- News (4w)
- 12
- 0
- Recent ratings
- 25
- 0
Venus Concept Inc.
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Velocity and Venus Epileve, a diode laser device for hair removal, permanent hair reduction, and treatment of ingrown hair; and Venus Fiore that is used for the treatment of vaginal canal, labia skin tightening, and mons pubis. The company also offers Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin; Venus Freeze Plus, a noninvasive device used in dermatologic and general surgical procedures for females for the noninvasive treatment of moderate to severe facial wrinkles and rhytides; Venus Bliss, a device is used for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance. In addition, it provides NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system; and ARTAS and ARTAS iX, a robotic systems to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Latest MDLN
- SEC Form 4 filed by Chief Executive Officer Boyle James M
- SEC Form 4 filed by Chief Operating Officer Miller Stephen L
- Large owner Gic Private Ltd sold $57,280,000 worth of shares (1,600,000 units at $35.80) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $21,002,305 worth of shares (590,284 units at $35.58) (SEC Form 4)
- Large owner Mozart Holdco, Inc. converted options into 500,000 shares and disposed of 500,000 units of Class B Common Stock, increasing direct ownership by 81,083% to 233,520,656 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.
- Large owner Gic Private Ltd sold $79,971,448 worth of shares (2,248,612 units at $35.56) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Medline Inc.
- SEC Form 10-Q filed by Medline Inc.
Latest VERO
- Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada
- Venus Concept Announces Senior Management Changes
- SEC Form D filed by Venus Concept Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Venus Concept Inc.
- Venus Concept Announces Completion of Common Stock Sale and Short-Form Merger
- SEC Form 4 filed by Madryn Asset Management, Lp
- SEC Form 4 filed by Ew Healthcare Partners, L.P.
- SEC Form EFFECT filed by Venus Concept Inc.
- SEC Form EFFECT filed by Venus Concept Inc.
- SEC Form EFFECT filed by Venus Concept Inc.